نتایج جستجو برای: immunogenic response

تعداد نتایج: 983179  

2017
Kamel Ait-Tahar Amanda P Anderson Martin Barnardo Graham P Collins Chris S R Hatton Alison H Banham Karen Pulford

Improved therapies are urgently needed for patients with diffuse large B cell lymphoma (DLBCL). Success using immune checkpoint inhibitors and chimeric antigen receptor T cell technology has fuelled demand for validated cancer epitopes. Immunogenic cancer testis antigens (CTAs), with their widespread expression in many tumours but highly restricted normal tissue distribution, represent attracti...

Journal: :iranian biomedical journal 0
جلال بابایی jalal babaie مهرک زارع mehrak zare غزاله صادقیانی ghazaleh sadeghiani محمد لرگرد دزفولی mohammad lorgard-dezfuli زهره عقیقی zohre aghighi مجید گلکار majid golkar

background: dense granule antigens (gra antigens) of toxoplasma gondii induce strong antibody response in humans and are considered as useful diagnostic antigens. previous studies reported expression of amino terminal gra8 protein in fusion with large tags such as glutathione-s-transferase. the present study aimed to produce soluble full length immunogenic gra8 in bacteria. methods: gra8 comple...

Journal: :The Journal of Experimental Medicine 2005
Noelia Casares Marie O. Pequignot Antoine Tesniere François Ghiringhelli Stéphan Roux Nathalie Chaput Elise Schmitt Ahmed Hamai Sandra Hervas-Stubbs Michel Obeid Frédéric Coutant Didier Métivier Evelyne Pichard Pierre Aucouturier Gérard Pierron Carmen Garrido Laurence Zitvogel Guido Kroemer

Systemic anticancer chemotherapy is immunosuppressive and mostly induces nonimmunogenic tumor cell death. Here, we show that even in the absence of any adjuvant, tumor cells dying in response to anthracyclins can elicit an effective antitumor immune response that suppresses the growth of inoculated tumors or leads to the regression of established neoplasia. Although both antracyclins and mitomy...

Journal: :The Journal of Experimental Medicine 1996
Y Li K E Hellstrom S A Newby L Chen

Genetic modification of many types of mouse tumors to express the B7-1 or B7-2 molecules, natural ligands for the T cell-costimulatory molecule CD28, increases their immunogenicity. However, even after transfection with the B7-1 and/or B7-2 genes, poorly immunogenic tumors fail to elicit and efficient immune response. We report here that two such tumors, the Ag104A sarcoma and the K1735-M2 mela...

2017
Namit Holay Youra Kim Patrick Lee Shashi Gujar

Cancer immunotherapy represents a promising, modern-age option for treatment of cancers. Among the many immunotherapies being developed, oncolytic viruses (OVs) are slowly moving to the forefront of potential clinical therapeutic agents, especially considering the fact that the first oncolytic virus was recently approved by the Food and Drug Administration for the treatment of melanoma. OVs wer...

2010
Andrea Cassinotti Simon Travis

INTRODUCTION Infliximab (IFX) has transformed the management of inflammatory bowel disease (IBD) [1,2]. It is a peptide and, like all proteins, is immunogenic. This means that the body recognizes the protein as foreign and generates antibodies in an endeavor to neutralize its impact. IFX is also expensive, costing £16456 ($26000) for induction and a year of maintenance therapy in the UK [3]. Dr...

2014
Lidice Bernardo Gregory A. Denomme Kunjlata Shah Alan H. Lazarus

The ability to study the immune response to the RhD antigen in the prevention of hemolytic disease of the fetus and newborn has been hampered by the lack of a mouse model of RhD immunization. However, the ability of transgenic mice expressing human HLA DRB1(*)1501 to respond to immunization with purified RhD has allowed this question to be revisited. In this work we aimed at inducing anti-RhD a...

2011
Sudhakar Reddy Kalluri Veit Rothhammer Ori Staszewski Rajneesh Srivastava Franziska Petermann Marco Prinz Bernhard Hemmer Thomas Korn

BACKGROUND Antibodies to the water channel protein aquaporin-4 (AQP4), which is expressed in astrocytic endfeet at the blood brain barrier, have been identified in the serum of Neuromyelitis optica (NMO) patients and are believed to induce damage to astrocytes. However, AQP4 specific T helper cell responses that are required for the generation of anti-AQP4 antibodies and most likely also for th...

Journal: :Cancer control : journal of the Moffitt Cancer Center 2013
Hatem Soliman

BACKGROUND Advances have been made in the field of cancer immunotherapy in understanding the role of the host immune response in affecting tumor progression and response to various treatments. Through these advances, two novel immunotherapies were introduced in the clinic for melanoma and prostate cancer. METHODS This review discusses the available data regarding the immune-modulating effects...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید